Practical Neurology

11/22/2025

For treatment, isoform-selective sodium channel inhibitors that spare GABAergic interneuron function are an exciting area of research. Dr. Raman Sankar reviews emerging selective sodium channel antagonists in a new article: https://ow.ly/hcQ450XvYlt
American Epilepsy Society American Academy of Neurology (AAN) UCLA American Academy of Neurology (AAN) David Geffen School of Medicine at UCLA

11/21/2025

For people with long- , treatment with for 26 days was not shown to improve functional capacity, respiratory measures, inflammatory markers, or patient-reported outcomes. Data published in JAMA Internal Medicine.
https://ow.ly/EuOJ50XuUY1
American Academy of Neurology (AAN) American Medical Association

Treatment with colchicine for 26 days was not shown to improve functional capacity, respiratory measures, inflammatory markers, or patient-reported outcom…

11/20/2025

Adding to standard -C–lowering therapy for people with or but no previous infarction or was shown to reduce risk for first major event.
https://ow.ly/yggJ50XuUmK
American Heart Association Endovascular Today American Academy of Neurology (AAN)

The addition of the proprotein convertase subtilisin/Kexin type 9 (PCSK9) enzyme inhibitor Repatha (evolocomab; Amgen, Thousand Oaks, CA) to standard low-…

11/20/2025

What should you tell patients about and ? Learn about the 3 main axis pathways for microplastics, what is currently known about the effects of those plastics on the CNS, and what you can do to protect yourself in a new Special Report: https://ow.ly/pNtn50XuUqy
American Academy of Neurology (AAN) Donald and Barbara Zucker School of Medicine at Hofstra/Northwell University of Miami American College of Occupational and Environmental Medicine American Medical Association

Microplastics and "Negative Neuroplasticity"

11/19/2025

Are you a who would like to use your expertise to assist in the publication of high-quality, educational case reports? If you're interested in volunteering as a reviewer for our journal, please message us or reply to this post. American Academy of Neurology (AAN)

11/17/2025

Progressive remains driven by compartmentalized CNS inflammation & rather than peripheral immune activity. In a new article, Drs Graham & Fox review BTK inhibition as a mechanistically distinct approach that may bridge both processes: https://ow.ly/R2lh50XpWp3

American Academy of Neurology (AAN) The Consortium of Multiple Sclerosis Centers National Multiple Sclerosis Society Cleveland Clinic American College of Physicians (ACP)

11/17/2025

Neurologists and movement disorder specialists Dr. Hauser and Dr. Morgan discussed the importance of a proactive, brain-health-first approach and access to innovation in disease treatment.

Don't Wait: Rethinking Parkinson's Disease Care for Brain Health

11/16/2025

The U.S. Food and Drug Administration has updated the label for following investigations into reports of fatal liver failure in nonambulatory patients with .
https://ow.ly/XiYU50Xs02v
American Association of Neuromuscular & Electrodiagnostic Medicine - AANEM Muscular Dystrophy Association American Academy of Neurology (AAN) American Medical Association

Following an investigation of reports of fatal liver failure, the Food and Drug Administration (FDA) has approved updated prescribing information for trea…

11/15/2025

🧠💤 Sleep-Related differ from parasomnias in both clinical impact & tx. Dr. Morris Chang's new article can help you to better recognize & manage SRMDs to improve patient QOL: https://ow.ly/uaTK50XpW8P
American Academy of Neurology (AAN) American Academy of Sleep Medicine International Parkinson and Movement Disorder Society American Medical Association

Sleep-Related Movement Disorders

11/14/2025

The U.S. Food and Drug Administration has granted Investigational Device Exemption for the system, an epicranial device for people with drug-resistant focal , authorizing the pivotal EASEE4US clinical study.
https://ow.ly/prEi50XrWR8
American Epilepsy Society Epilepsy Foundation of America American Academy of Neurology (AAN)

The Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for the EASEE4US clinical study, allowing PRECISIS (Hei…

11/13/2025

Our November issue with Medical Editor Joyce Matsumoto, MD (David Geffen School of Medicine at UCLA) explores therapies and strategies for the care of children and adults with epilepsy, from emerging options, to , , and more.

Read our new issue today: https://ow.ly/HML950XqMRF

American Epilepsy Society Epilepsy Foundation of America American Academy of Neurology (AAN) American Academy of Pediatrics Child Neurology Society

11/12/2025

Older nursing home residents who use both and a -inhibiting may have a higher risk of , according to research published in Neurology Journal.
https://ow.ly/S9iG50XqQhl
American Academy of Neurology (AAN) American Epilepsy Society Gerontological Society of America ASIPP American Society of Pain & Neuroscience

Older nursing home residents who take tramadol together with antidepressants that inhibit the CYP2D6 enzyme may face a higher risk of seizures, according …